71 – 80 of 776
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
- Contribution to journal › Article
- 2022
-
Mark
Editorial : Methods and applications in inflammation pharmacology
- Contribution to journal › Debate/Note/Editorial
-
Mark
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside
- Contribution to journal › Article
-
Mark
Engineering the Ligand Specificity of the Human Galectin-1 by Incorporation of Tryptophan Analogues
- Contribution to journal › Article
-
Mark
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation
- Contribution to journal › Article
-
Mark
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia
- Contribution to journal › Article
-
Mark
Immunomodulation therapy offers new molecular strategies to treat UTI
- Contribution to journal › Scientific review
-
Mark
Comorbidities in hereditary angioedema—A population-based cohort study
- Contribution to journal › Article
-
Mark
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
- Contribution to journal › Article
-
Mark
Steroid glycosides isolated from Paris polyphylla var. chinensis aerial parts and paris saponin II induces G1/S-phase MCF-7 cell cycle arrest
- Contribution to journal › Article
